Article
CD105 is important for angiogenesis: evidence and potential applications.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology - 1 Jun 2003
Duff Sarah E, Li Chenggang, Garland John M, Kumar Shant
Abstract excerpt
Angiogenesis is the propelling force for tumor growth and metastasis, and antiangiogenic therapy represents one of the most promising modalities for cancer treatment. CD105 (endoglin) is a proliferation-associated and hypoxia-inducible protein abundantly expressed in angiogenic endothelial cells (EC). It is a receptor for transforming growth factor (TGF) -beta1 and -beta3 and modulates TGF-beta signaling by...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
